Lawrenceville, NJ, United States of America

Luigi Mapelli

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Adare Pharmaceuticals, Inc.. Active years: 2024.


% Patents Active = 100.0



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luigi Mapelli: Innovator in Drug Delivery Systems

Introduction

Luigi Mapelli is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. His innovative work focuses on enhancing the solubility and effectiveness of weakly basic drugs.

Latest Patents

Luigi Mapelli holds a patent for "Drug delivery systems comprising solid solutions of weakly basic drugs." This invention is directed to pharmaceutical compositions and dosage forms that utilize TPR beads. These beads comprise a solid dispersion of at least one active pharmaceutical ingredient in a solubility-enhancing polymer, along with a TPR coating that includes a water-insoluble polymer and an enteric polymer. The active pharmaceutical ingredient is characterized as a weakly basic compound with limited solubility at pH 6.8.

Career Highlights

Luigi Mapelli is currently associated with Adare Pharmaceuticals, Inc., where he continues to develop innovative pharmaceutical solutions. His work is instrumental in advancing drug delivery technologies that improve patient outcomes.

Collaborations

Throughout his career, Luigi has collaborated with esteemed colleagues, including Gopi M Venkatesh and Luigi Boltri. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical technologies.

Conclusion

Luigi Mapelli's contributions to drug delivery systems exemplify his commitment to innovation in the pharmaceutical industry. His patent and ongoing work at Adare Pharmaceuticals, Inc. highlight his role as a key figure in advancing drug formulation technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…